Bristol-Myers
Squibb Company (NYSE: BMY) will take part in the Jefferies London
Healthcare Conference on Wednesday, November 15, 2017, in London. John
Elicker, senior vice president, Corporate Affairs and Investor
Relations, will answer questions about the company at 10:40 a.m. GMT.
Investors and the general public are invited to listen to a live webcast
of the session at http://investor.bms.com.
Materials related to the presentation will be available at the same
website at the start of the live webcast. An archived edition of the
session will be available later that day.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global
biopharmaceutical company whose mission is to discover, develop and
deliver innovative medicines that help patients prevail over serious
diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, Twitter,
YouTube
and Facebook.
Bristol-Myers Squibb Media:Ken Dominski, 609-252-5251 ken.dominski@bms.com or Investors:Tim Power, 609-252-7509 timothy.power@bms.com orBill Szablewski, 609-252-5894 william.szablewski@bms.com